Business, energy, technology, markets and global industry news from Business News Today

nitric oxide donation

Pharma & Biotech

What Nicox SA’s NCX 470 presentations signal for nitric oxide–based eye therapies

Discover how Nicox SA’s NCX 470 Phase 3 data could reshape glaucoma treatment and regulatory strategy. Read the full analysis.

Read More